◀ Back to BCL3

BCL3 — MMP1

Text-mined interactions from Literome

Elliott et al., Arthritis Rheum 2002 : To define the role of Bcl-3 , a member of the inhibitor of nuclear factor kappaB (NF-kappaB) family and a known regulator of NF-kappaB, in interleukin-1 (IL-1) induced matrix metalloproteinase 1 (MMP-1) transcription in chondrocytes and synovial fibroblasts ... Exogenous expression of Bcl-3 in SW-1353 cells activated MMP-1 transcription ... Endogenous Bcl-3 expression was required for IL-1beta induction of MMP-1 gene expression ... Bcl-3 also activated MMP-1 transcription in primary synovial fibroblasts
Elliott et al., Arthritis Res Ther 2003 (Bone Neoplasms...) : Overexpression of Bcl-3 increased MMP-1 , but not MMP-13, mRNA levels
Lecoeur et al., Cell death & disease 2012 : Pharmacologic inhibitors of the permeability transition pore, Bax/Bak inhibitors, and recombinant Bcl-2 and Bcl-XL proteins do not reduce Tat induced MMP
Arbab et al., Evidence-based complementary and alternative medicine : eCAM 2012 : We found that dentatin mediated accumulation of reactive oxygen species ( ROS ) and downregulated expression levels of antiapoptotic molecules ( Bcl-2, Bcl-xL , and Survivin ), leading to disruption of mitochondrial membrane potential ( MMP ) , cell membrane permeability, and release of cytochrome c from the mitochondria into the cytosol